Skip to ContentSkip to Navigation
About us Practical matters How to find us prof. dr. E.M.D. (Ed) Schuuring

Publications

Costs of biomarker testing in advanced non-small cell lung cancer: a global study comparing next-generation sequencing and single-gene testing

Genome-Wide DNA Methylation and Copy Number Alterations in Gastrointestinal Stromal Tumors

Molecular Testing as Triage in Cervical Cancer Screening: Economic Evaluation Using Headroom Analysis

Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer

Reporting of molecular test results from cell-free DNA analyses: expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA Workshop

Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology

Vvax001, a Therapeutic Vaccine for Patients with HPV16-positive High-grade Cervical Intraepithelial Neoplasia: a Phase II Trial

Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial

112P Reporting of molecular test results from cell-free DNA analyses: Expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA workshop

Addition of tumor microenvironment immune cell composition to improve the performance of a predictive model for oral squamous cell carcinoma

Press/media

Delivering molecular pathology at lower costs

Doelgerichte therapie bij longkanker

Naar een heel nieuw systeem voor kankerzorg en -diagnostiek

Commissie Beoordeling Diagnostiek

Organisatie moleculaire diagnostiek bij mammacarcinoom

At ESMO, Focusing on Non-Small Cell Lung Cancer

Longkanker: welke vorm heb ik?

25 jaar Moleculaire Diagnostiek binnen de Pathologie in Nederland

Moleculaire diagnostiek volop in beweging